AMICUS THERAPEUTICS INC (FOLD) Stock Balance Sheet
NASDAQ:FOLD • US03152W1099
Current stock price
14.45 USD
+0.01 (+0.07%)
At close:
14.4653 USD
+0.02 (+0.11%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 214.01M | 213.75M | 246.99M | 148.80M | 245.20M | |||
| Marketable Securities | 79.53M | 36.19M | 39.21M | 144.80M | 237.30M | |||
| Receivables | 115.31M | 101.10M | 87.63M | 66.20M | 52.70M | |||
| Inventories | 228.82M | 118.78M | 59.70M | 23.80M | 26.80M | |||
| Other Current Assets | 38.51M | 34.91M | 49.53M | 40.20M | 34.80M | |||
| Total Current Assets | 676.17M | 504.74M | 483.06M | 423.80M | 596.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 48.25M | 51.66M | 57.98M | 60.30M | 63.10M | |||
| Goodwill | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M | |||
| Intangibles | 13.91M | 17.20M | 20.49M | 23.00M | 23.00M | |||
| Other Non-Current Assets | 13.74M | 13.64M | 18.55M | 19.20M | 24.40M | |||
| Total Non-Current Assets | 273.70M | 280.30M | 294.82M | 300.40M | 308.30M | |||
| TOTAL ASSETS | 949.87M | 785.03M | 777.88M | 724.20M | 905.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 168.71M | 108.94M | 129.76M | 88.70M | 95.20M | |||
| Accounts Payable | 28.63M | 12.95M | 15.12M | 15.40M | 21.50M | |||
| Other Current Liabilities | 40.49M | 26.81M | 22.80M | 34.90M | 29.30M | |||
| Total Current Liabilities | 237.83M | 148.70M | 167.69M | 139.00M | 146.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 392.66M | 390.11M | 387.86M | 392.00M | 389.40M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 4.90M | 4.90M | |||
| Other Non-Current Liabilities | 45.14M | 52.17M | 62.16M | 65.20M | 57.50M | |||
| Total Non-Current Liabilities | 437.80M | 442.29M | 450.02M | 462.10M | 451.80M | |||
| TOTAL LIABILITIES | 675.63M | 590.99M | 617.71M | 601.10M | 597.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.77B | -2.74B | -2.68B | -2.53B | -2.30B | |||
| Additional Paid In Capital | 3.01B | 2.93B | 2.84B | 2.66B | 2.60B | |||
| Common Shares | 3.04M | 2.94M | 2.92M | 2.80M | 2.80M | |||
| Treasury Stock | -71.00K | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 24.12M | 5.30M | 5.43M | -12.00M | 5.30M | |||
| Shares Outstanding | 310.85M | 299.04M | 293.59M | 281.10M | 278.90M | |||
| Tangible Book Value per Share | 0.20 | -0.07 | -0.20 | -0.35 | 0.31 | |||
| Total Shareholders' Equity | 274.24M | 194.04M | 160.17M | 123.00M | 307.40M | |||
| TOTAL LIABILITIES AND EQUITY | 949.87M | 785.03M | 777.88M | 724.20M | 905.10M | |||
| Statistics | ||||||||
| Debt/Equity | 1.43 | 2.01 | 2.42 | 3.19 | 1.27 | |||
| Current Ratio | 2.84 | 3.39 | 2.88 | 3.05 | 4.09 | |||
| Return On Assets (ROA) | -2.85% | -7.15% | -19.49% | -32.67% | -27.68% | |||
| Return On Equity (ROE) | -9.89% | -28.91% | -94.64% | -192.36% | -81.49% | |||
| Return On Invested Capital (ROIC) | 3.83% | 4.23% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 6.51% | 6.96% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 13.18% | 15.70% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21